Nanotechnology-Based Chimeric Antigen Receptor T-Cell Therapy in Treating Solid Tumor

Investigators systematically introduce the components of different generation of CARs and summarize recent innovations in nano-based CAR-T cell therapy to conquer therapeutically resistant non-hematologic malignancies.